Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari

Brand / Medicines

 

At Napp, we have a strong track record of providing medicines that meet patient needs.

Our medicines

    Invokana®

    (canagliflozin hemihydrate) tablets

    Prescribing information for

    Great Britain Northern Ireland Get More Information

    Herzuma®

    (trastuzumab) powder for concentrate for solution for infusion

    Prescribing information for

    Great Britain Northern Ireland

    Pelmeg®

    (pegfilgrastim) solution for injection in pre-filled syringe

    Prescribing information for

    Great Britain Northern Ireland

    Truxima®

    (rituximab) concentrate for solution for infusion

    Prescribing information for

    Great Britain Northern Ireland Administration Route Safety Sheet

    Adizem-XL®

    (diltiazem hydrochloride) prolonged release capsules

    For prescribing information

    Click here

    Adizem-SR®

    (diltiazem hydrochloride) prolonged release capsules

    For prescribing information

    Click here

    Invokana®

    (canagliflozin hemihydrate) tablets

    Prescribing information for

    Great Britain Northern Ireland Get More Information

    Vokanamet®

    (canagliflozin hemihydrate/ metformin hydrochloride) tablets

    Prescribing information for

    Great Britain Northern Ireland

    Herzuma®

    (trastuzumab) powder for concentrate for solution for infusion

    Prescribing information for

    Great Britain Northern Ireland

    Pelmeg®

    (pegfilgrastim) solution for injection in pre-filled syringe

    Prescribing information for

    Great Britain Northern Ireland

    Truxima®

    (rituximab) concentrate for solution for infusion

    Prescribing information for

    Great Britain Northern Ireland Administration Route Safety Sheet

    Important Safety Information

    BuTrans®

    (buprenorphine) 5, 10 and 20 mcg/hr patches

    For prescribing information

    Click here

    BuTrans®

    (buprenorphine) 15 mcg/hr patches

    For prescribing information

    Click here

    DHC® Continus®

    (dihydrocodeine tartrate) prolonged release tablets

    For prescribing information

    Click here

    MST® Continus®

    (morphine sulphate) prolonged release tablets

    For prescribing information

    Click here

    MXL®

    (morphine sulphate) prolonged release capsules

    For prescribing information

    Click here

    OxyContin®

    (oxycodone hydrochloride) prolonged release tablets

    For prescribing information

    Click here

    OxyNorm®

    (oxycodone hydrochloride) capsules

    For prescribing information

    Click here

    OxyNorm®

    (oxycodone hydrochloride)10 mg/ml solution for injection or infusion

    For prescribing information

    Click here

    OxyNorm®

    (oxycodone hydrochloride)50 mg/ml solution for injection or infusion

    For prescribing information

    Click here

    OxyNorm®

    (oxycodone hydrochloride)1 mg/ml oral liquid

    For prescribing information

    Click here

    OxyNorm®

    (oxycodone hydrochloride)10 mg/ml oral concentrate

    For prescribing information

    Click here

    Palladone® SR

    (hydromorphone hydrochloride) prolonged release capsules

    For prescribing information

    Click here

    Palladone®

    (hydromorphone hydrochloride) capsules

    For prescribing information

    Click here

    Palladone®

    (hydromorphone hydrochloride) solution for injection or infusion

    For prescribing information

    Click here

    Sevredol®

    (morphine sulphate) tablets

    For prescribing information

    Click here

    Targinact®

    (oxycodone hydrochloride/ naloxone hydrochloride) prolonged release tablets

    For prescribing information

    Click here

    Transtec®

    (buprenorphine) patches

    For prescribing information

    Click here
    Overdose Therapy

    Addiction is a complex, relapsing, chronic disease, which can carry serious health and social consequences. At Napp, we share the concerns of patients and their families working through the illness of heroin addiction, and believe that people living with heroin addiction deserve the best available care. Overdose is a dangerous potential consequence of opioid misuse or abuse, and in particular abuse of illegal heroin. By supplying Nyxoid, Napp are providing another option for treating such instances of overdose.

    Nyxoid®

    (naloxone hydrochloride dihydrate) intranasal spray

    Prescribing information for

    Great Britain Northern Ireland Healthcare Professional Guidance Document

    flutiform®

    (fluticasone propionate / formoterol fumarate dihydrate) pressurised metered dose inhaler

    For prescribing information 

    Click here

    Uniphyllin® Continus®

    (theophylline) prolonged release tablets

    For prescribing information 

    Click here

    Reporting adverse events

    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

    Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyuk@napp.co.uk.